Meet the Members of the Canadian Network for Research in Schizophrenia and Psychosis !
Member | Identification | Affiliation |
|---|---|---|
Elisabeth Thibaudeau | Researcher | McGill University and Douglas Research Centre |
Faydra Aldridge | Organization | British Columbia Schizophrenia Society |
Faye Doell | Clinician | Laksman Doell Psychology |
Florence Budden | Clinician | Schizoprenia Society of Canada, Canadian Alliance on Mental Illness and Mental Health |
Hayley Riel | Researcher | University of Manitoba |
Hector Caruncho | Researcher | University of Victoria; Division of Medical Sciences and Mental Health Research Cluster |
Howard Margolese | Clinician/Researcher | Program for the evaluation and prevention of psychosis, Clinical Pharmacology and Toxicology residency program, McGill University, Department of psychiatry, McGill University |
Iris Kairow | Family Member | Mothers for Mental Health Care Reform |
J. Bruno Debruille | Clinician/Researcher | Douglas Mental Health University Institute |
Jean Manneville Theagene | Clinician/person with lived experience | Centre hospitalier de l'Université de Montréal |
Jean Margaret Addington | Researcher | Department of Psychiatry, University of Calgary |
Jibran Khokhar | Researcher | Canada Research Chair in Translational Neuropsychopharmacology |
Partners & Organizations
Alice Charasse
Executive Director
Chris Summerville
Chief Executive Officer
Chris Watkins
Board of Directors
Amal Abdel-Baki, MD,
Director at Large
André jr Turcotte
Head of Unit
Michel Gilbert
Coordinator
Faydra Aldridge
Chief Executive Officer
Aristotle Voineskos
Director
George Foussias
Scientific Director and Chief
Slaight Family Centre for Youth in Transition and Schizophrenia Division
Alice Charasse
Executive Director
Chris Summerville
Chief Executive Officer
Chris Watkins
Board of Directors
Amal Abdel-Baki, MD,
Director at Large
André jr Turcotte
Head of Unit
Michel Gilbert
Coordinator
Aristotle Voineskos
Director
George Foussias
Scientific Director and Chief
Slaight Family Centre for Youth in Transition and Schizophrenia Division
Faydra Aldridge
Chief Executive Officer